Kwangdong Healthbio Co (XKRX:086220) Change In Receivables : ₩-3,673 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Kwangdong Healthbio Co Change In Receivables?

Kwangdong Healthbio Co's change in receivables for the quarter that ended in Dec. 2023 was ₩-3,673 Mil. It means Kwangdong Healthbio Co's Accounts Receivable increased by ₩3,673 Mil from Dec. 2022 to Dec. 2023 .

Kwangdong Healthbio Co's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-3,673 Mil. It means Kwangdong Healthbio Co's Accounts Receivable increased by ₩3,673 Mil from Dec. 2022 to Dec. 2023 .

Kwangdong Healthbio Co's Accounts Receivable for the quarter that ended in Dec. 2023 was ₩10,470 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Kwangdong Healthbio Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 23.84.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kwangdong Healthbio Co's liquidation value for the six months ended in Dec. 2023 was ₩-24,837 Mil.

Kwangdong Healthbio Co Change In Receivables Historical Data

The historical data trend for Kwangdong Healthbio Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwangdong Healthbio Co Change In Receivables Chart

Kwangdong Healthbio Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

3,236.60

-3,461.69

-3,158.98

1,825.19

-3,673.39

Kwangdong Healthbio Co Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Change In Receivables	Get a 7-Day Free Trial					3,236.60	-3,461.69	-3,158.98	1,825.19	-3,673.39

Kwangdong Healthbio Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-3,673 Mil.

Kwangdong Healthbio Co (XKRX:086220) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kwangdong Healthbio Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	10470.254	/	80157.299	*	91
=	23.84

2. In Ben Graham's calculation of liquidation value, Kwangdong Healthbio Co's accounts receivable are only considered to be worth 75% of book value:

Kwangdong Healthbio Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3726.84	-	38845.991	+	0.75 * 10470.254	+	0.5 * 4858.042
=	-24,837

Kwangdong Healthbio Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kwangdong Healthbio Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kwangdong Healthbio Co (XKRX:086220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwangdong Healthbio Co Ltd (XKRX:086220) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bundang Suji U-Tower, 767 Sinsu-ro, 7th floor, Building A, Yongin-si, Gyeonggi-do, Suji-gu, KOR

Website

http://www.bl-healthcare.com

BL Healthcare Corp is a Bio-venture company, which develops, manufactures, and sells health functional food and pharmaceutical products. The Company's products include weight-loss pills, vitamins, and other nutrition supplements. It also produces personal care items such as cosmetics, hair care products, and skincare products.

Kwangdong Healthbio Co (XKRX:086220) Headlines

No Headlines